This study is testing a new procedure called RF Vapor Ablation of the proximal intestinal mucosa to see if it's safe, tolerable, and effective for people with Type 2 Diabetes. This procedure uses radiofrequency vapor to treat the lining of the upper part of the small intestine. Researchers want to see if this treatment can improve blood sugar levels (measured by HbA1c) without causing serious side effects or unexpected problems with the device. You might be able to join if you are 22-65 years old, have Type 2 Diabetes for 1-15 years, and your HbA1c is between 7.5% and 10%. The study is currently unclear about its recruitment status.

Study design

This is an interventional study with a planned enrollment of 20 participants. It is a pilot human investigation, meaning it's an early study to gather initial information.

What's involved

Your participation would involve a screening phase, a run-in phase, pre-procedure tests, the RF Vapor ablation procedure, and follow-up visits for up to 168 days.

Compensation

Not stated in the trial record.

Follow-up

You would be followed for 6 months after the procedure to check safety and effectiveness, and for 14 days to check tolerability.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.